These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10506125)

  • 1. Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease.
    Hashimoto M; Takeda A; Hsu LJ; Takenouchi T; Masliah E
    J Biol Chem; 1999 Oct; 274(41):28849-52. PubMed ID: 10506125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ceruloplasmin and hydrogen peroxide system induces alpha-synuclein aggregation in vitro.
    Kim KS; Choi SY; Kwon HY; Won MH; Kang TC; Kang JH
    Biochimie; 2002 Jul; 84(7):625-31. PubMed ID: 12453634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.
    Hashimoto M; Hsu LJ; Xia Y; Takeda A; Sisk A; Sundsmo M; Masliah E
    Neuroreport; 1999 Mar; 10(4):717-21. PubMed ID: 10208537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.
    Hashimoto M; Kawahara K; Bar-On P; Rockenstein E; Crews L; Masliah E
    J Mol Neurosci; 2004; 24(3):343-52. PubMed ID: 15655259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
    Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
    Tabner BJ; Turnbull S; El-Agnaf OM; Allsop D
    Free Radic Biol Med; 2002 Jun; 32(11):1076-83. PubMed ID: 12031892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Synuclein filaments bind the transcriptional regulator HMGB-1.
    Lindersson EK; Højrup P; Gai WP; Locker D; Martin D; Jensen PH
    Neuroreport; 2004 Dec; 15(18):2735-9. PubMed ID: 15597044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
    Kim KS; Choi SY; Kwon HY; Won MH; Kang TC; Kang JH
    Free Radic Biol Med; 2002 Mar; 32(6):544-50. PubMed ID: 11958955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
    Paik SR; Shin HJ; Lee JH
    Arch Biochem Biophys; 2000 Jun; 378(2):269-77. PubMed ID: 10860544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro.
    Turnbull S; Tabner BJ; El-Agnaf OM; Moore S; Davies Y; Allsop D
    Free Radic Biol Med; 2001 May; 30(10):1163-70. PubMed ID: 11369507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients.
    Piao YS; Wakabayashi K; Hayashi S; Yoshimoto M; Takahashi H
    Clin Neuropathol; 2000; 19(4):163-9. PubMed ID: 10919347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.
    Mukaetova-Ladinska EB; Hurt J; Jakes R; Xuereb J; Honer WG; Wischik CM
    J Neuropathol Exp Neurol; 2000 May; 59(5):408-17. PubMed ID: 10888371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced oligomerization of the alpha-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
    Kang JH; Kim KS
    Mol Cells; 2003 Feb; 15(1):87-93. PubMed ID: 12661766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.
    Ostrerova-Golts N; Petrucelli L; Hardy J; Lee JM; Farer M; Wolozin B
    J Neurosci; 2000 Aug; 20(16):6048-54. PubMed ID: 10934254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein in Lewy body disease and Alzheimer's disease.
    Hashimoto M; Masliah E
    Brain Pathol; 1999 Oct; 9(4):707-20. PubMed ID: 10517509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
    Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
    J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
    Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
    Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.
    Lindersson E; Lundvig D; Petersen C; Madsen P; Nyengaard JR; Højrup P; Moos T; Otzen D; Gai WP; Blumbergs PC; Jensen PH
    J Biol Chem; 2005 Feb; 280(7):5703-15. PubMed ID: 15590652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.